Updated time: 2022-07-25 15:46:03
This invention concerns the development and use of spin-containing luminescence molecules or nanoparticles as labels, markers, and reporters for ultrasensitive biomedical assays to meet the needs of immediate and sensitive detection of diseases, infections, and abnormality of human beings. Using fluorescent nanodiamonds (FNDs) as reporters and a magnetic modulation technique to selectively detect FND signals, we have established a world-leading, ultrasensitive spin-enhanced lateral flow immunoassay (SELFIA) platform. The method is well suited for rapid antibody screening, outperforming the commonly used enzyme-linked immunosorbent assay (ELISA). It is also applicable to improve the detection sensitivity of currently used lateral flow immunoassays (LFIA) for COVID-19 and related infectious diseases, effectively reducing false negative results.
- A completely new invention
- Holding a US Patent 8,963,075 “Luminescent diamond particles”, which are best suited for this application
- Outperforming ELISA in speed and LFIA in sensitivity
- A prototype of the platform named SELFIA has been completed and ready for technology transfer

Fig1. Schematic illustration of SELFIA. Fluorescent nanodiamonds (FNDs) are used as the reporters to achieve rapid and efficient antibody pair screening on the LFIA strip in this specific example.
07A-1090807
2020-11-10
TW I771198
- Rapid antibody screening and pairing with higher speed and efficiency than ELISA
- Detecting COVID-19 and other infectious diseases (e.g. influenza viruses) with less false negative results than colloidal gold-based LFIA
- Integrable with polymerase chain reaction (PCR) techniques for single DNA and RNA detection to shorten diagnostic times
Huan-Cheng Chang, Hui Yuen Yung, Hsin-Hung Lin, Oliver Y. Chen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Fig2. SELFIA (left) and its schematic diagram (right).

Spin-Enhanced Bioassays